|4Nov 10, 5:05 PM ET

Buchbinder Aby 4

4 · ENZON PHARMACEUTICALS INC · Filed Nov 10, 2011

Insider Transaction Report

Form 4
Period: 2011-11-08
Buchbinder Aby
VP, Clinical Development
Transactions
  • Sale

    Common Stock

    2011-11-08$7.06/sh2,700$19,06254,015 total

Documents

1 file
  • 4
    c67539_4.xmlPrimary

    OWNERSHIP DOCUMENT